Back

A TERRA–NONO Axis Drives Fibroblast Reprogramming in Cancer

CICCO, E.;ISMA, J.;SOL, S.;RESTIVO, G.;KATARKAR, A.;GORUPPI, S.;WHITE, J.;HAFNER, J.;MANDINOVA, A.;LEVESQUE, M.;DOTTO, G.

2026-06-11 Cancer Biology
10.64898/2026.06.08.730872 bioRxiv
Show abstract

The molecular mechanisms linking chromosome homeostasis to fibroblast reprogramming into cancer-associated fibroblasts (CAFs) remain poorly understood. Here, we identify a clinically relevant, telomere-associated nuclear pathway that drives CAF activation across multiple human cancers. The long non-coding RNA TERRA is consistently elevated in CAFs from skin, lung, and breast tumors. We show that the androgen receptor (AR) normally represses TERRA transcription by binding subtelomeric regions. Loss of AR releases this repression, allowing TERRA to interact with the RNA-binding protein NONO, forming a CAF-specific nuclear complex that reprograms transcription toward a tumor-promoting state. Disrupting the TERRA-NONO complex, through TERRA silencing or pharmacologic NONO inhibition, reverses CAF activation and suppresses tumor-stroma interactions both in vitro and in vivo. Importantly, NONO inhibition restores normal fibroblast features in patient-derived actinic keratoses, cutaneous squamous cell carcinomas, and melanomas, underscoring the translational potential of this pathway and positioning the TERRA-NONO complex as a promising therapeutic target.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.